Cargando…

Pomalidomide-induced changes in the pancreatic tumor microenvironment and potential for therapy

Detalles Bibliográficos
Autor principal:	Storz, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768848/ https://www.ncbi.nlm.nih.gov/pubmed/31608297 http://dx.doi.org/10.18632/oncoscience.486

Ejemplares similares

Inflammatory macrophages in pancreatic acinar cell metaplasia and initiation of pancreatic cancer
por: Liou, Geou-Yarh, et al.
Publicado: (2015)

Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment
por: Xu, Junfeng, et al.
Publicado: (2023)

Pomalidomide-induced hypothyroidism
por: Ali, Sulaiman Haji, et al.
Publicado: (2017)

Pancreatic cancer microenvironment, to target or not to target?
por: Carr, Ryan M, et al.
Publicado: (2016)

Profile of pomalidomide and its potential in the treatment of myelofibrosis
por: Gowin, Krisstina L, et al.
Publicado: (2015)

Pomalidomide promotes chemosensitization of pancreatic cancer by inhibition of NF-κB
por: Shirai, Yoshihiro, et al.
Publicado: (2018)

Pomalidomide Shows Significant Therapeutic Activity against CNS Lymphoma with a Major Impact on the Tumor Microenvironment in Murine Models
por: Li, Zhimin, et al.
Publicado: (2013)

Population Pharmacokinetics of Pomalidomide
por: Li, Yan, et al.
Publicado: (2015)

Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics
por: Ijichi, Hideaki
Publicado: (2022)

Pomalidomide-Induced Pulmonary Toxicity in Multiple Myeloma
por: Modi, Dipenkumar, et al.
Publicado: (2015)

Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivo
por: Saito, Nobuhiro, et al.
Publicado: (2018)

Single-cell RNA-Seq unveils tumor microenvironment
por: Lee, Hae-Ock, et al.
Publicado: (2017)

Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
por: Wu, Lingxiang, et al.
Publicado: (2023)

Involvement of lncRNAs in the tumor microenvironment: a new property of tumor immunity
por: Lin, Qingyu, et al.
Publicado: (2023)

Pomalidomide for the Treatment of Multiple Myeloma
por: Clark, Stephen M., et al.
Publicado: (2014)

Pomalidomide-induced lung injury: A case report
por: Vivien, Alexandre, et al.
Publicado: (2023)

Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy
por: Ríos-Tamayo, Rafael, et al.
Publicado: (2017)

Novel Therapeutic Targets in the Brain Tumor Microenvironment
por: Phillips, Joanna J.
Publicado: (2012)

Modeling the tumor immune microenvironment for drug discovery using 3D culture
por: Lee, Joanna Y., et al.
Publicado: (2021)

Spotlight on pomalidomide: could less be more?
por: Zander, T, et al.
Publicado: (2017)

Effect of microenvironment modulation on stem cell therapy for spinal cord injury pain
por: Liu, Sufang, et al.
Publicado: (2014)

Targeting Tumors with Salmonella Typhimurium - Potential for Therapy
por: Wall, Daniel M., et al.
Publicado: (2011)

Synthesis and Anti-Tumor Effects of Novel Pomalidomide Derivatives Containing Urea Moieties
por: Guo, Yajie, et al.
Publicado: (2022)

Exosomes: Emerging Players of Intercellular Communication in Tumor Microenvironment
por: Maheshwari, Shrankhla, et al.
Publicado: (2014)

Pomalidomide Reduces Ischemic Brain Injury in Rodents
por: Tsai, Yan-Rou, et al.
Publicado: (2019)

Enhancing antibody patent protection using epitope mapping information
por: Deng, Xiaoxiang, et al.
Publicado: (2017)

Microenvironment-mediated cancer dormancy: Insights from metastability theory
por: Bakhshandeh, Sadra, et al.
Publicado: (2021)

Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
por: Sonneveld, Pieter, et al.
Publicado: (2022)

Locoregional Therapies and Remodeling of Tumor Microenvironment in Pancreatic Cancer
por: De Grandis, Maria Caterina, et al.
Publicado: (2023)

Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor
por: North, Brian J., et al.
Publicado: (2017)

The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy
por: Berghella, Anna Maria, et al.
Publicado: (2011)

Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer: targeting the androgen receptor-regulated tumor immune microenvironment
por: Cheng, Bisheng, et al.
Publicado: (2023)

Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
por: Gillson, Josef, et al.
Publicado: (2020)

New drugs in multiple myeloma – role of carfilzomib and pomalidomide
por: Jurczyszyn, Artur, et al.
Publicado: (2014)

Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
por: Chanan-Khan, A A, et al.
Publicado: (2013)

Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
por: Sivaraj, Dharshan, et al.
Publicado: (2018)

Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
por: Wang, Jin-Ya, et al.
Publicado: (2016)

The Tumor Microenvironment of Pancreatic Cancer
por: Karamitopoulou, Eva
Publicado: (2020)

Neutrophil in the Pancreatic Tumor Microenvironment
por: Jin, Lin, et al.
Publicado: (2021)

Future directions of neoadjuvant therapy in pancreatic cancer
por: Mota Reyes, Carmen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ub0arbf3gcobrpnchk82dr539b